Welcome to the DarkDaily.com White Paper Library
Created and maintained as a service to the Clinical and Anatomic Pathology Industry, this unique White Paper program provides laboratory executives with:
- An important and useful resource for knowledge and information about the management of labs
- A direct link between the educational topics of each White Paper and related Industry businesses
Download any White Paper in the library absolutely FREE of charge!
Check out our library below with its many important and useful topics, then take advantage of our free download service. Contact Ron Martin today at 512-264-7103 to learn more about our successful White Paper program and how you can be a part of it!
Just Posted! Molecular Information Management Systems (MIMS): Pathologists are Using MIMS To Revolutionize Personalized and Predictive Medicine
A Lab Leader’s Guide To Pharmacogenomic Testing (PGx): Cloud-Based SoftwareReporting of PGx for Hospitals, Health Systems and Clinical Laboratories
Integrating Clinical Laboratories into Healthcare Networks: Using clinical exchange and elegant workflow design to enhance service value and reduce costs
This FREE White Paper providing you with a detailed discussion on the complexities of integrated healthcare networks, and how clinical diagnostic laboratories can utilize a clinical exchange solution to cut costs and improve workflow.
A Laboratory Executive’s Guide to Intelligently Reducing Costs While Achieving Operational Excellence and Superior Client Service: Using the Healthcare Cloud to Remain Competitive in Today’s Environment
Collecting More Dollars From Patients: Why It’s Time For Clinical Labs and Pathology Groups to Move To The Retail Model
UPDATED CONTENT! Harnessing the Power of Real-Time Analytics to Achieve World Class Performance in Clinical Laboratories and Pathology Groups
This free clinical laboratory white paper will address current trends in health care and the clinical laboratory testing marketplace, deficiencies in today’s generation of medical laboratory information systems, how lab-focused business analytics can be applied to Lean quality processes, and provide in-depth case studies of clinical laboratories utilizing business software solutions to meet those goals.
CPOE and Meaningful Use Stage Two: How the Adoption of Cloud-Based CPOE Can Ease the Burden of Satisfying Meaningful Use Requirements for Your Lab and Your Physicians
Most clinical laboratory managers know that the HITECH Act, part of the American Recovery and Reinvestment Act (“ARRA”) of 2009, was designed to promote and expand the adoption of health information technology (“HIT”). To that end, the U.S. Department of Health and Human Services (“HHS”) was allotted $25.9 billion to create incentives and to fund the adoption of HIT. Expansion and adoption of HIT will necessarily impact the spectrum of healthcare providers, including hospitals, physicians, medical laboratories and pathology groups.
Proven Strategies That Go Beyond Clinical Excellence: Combining Lab-Specific CRM and Healthcare Business Intelligence to Differentiate Your Clinical Laboratory or Pathology Group
Increasing competition. Reimbursement cuts coming from countless angles. Mounting pressure to shift healthcare to a fee-for-value paradigm. Among a perfect storm of factors threatening the future profitability of labs that have historically grown at a healthy rate, there’s never been a more urgent time for clinical and anatomic pathology laboratories to focus on non-clinical aspects of their business in order to differentiate themselves.
The ultimate goal of any commercial venture is to increase profitability. Significantly increasing overall profitability frequently requires substantial changes to a business (e.g., mergers/ acquisitions, in-licensing or developing new products, or divestiture of unprofitable business units). Building on earlier white papers in the CEO’s Guide series, this white paper will look at relatively benign changes that clinical laboratory management can undertake. Although less dramatic than other options, they can still result in a doubling of lab profitability.
A CEO’s Guide to Next Generation Revenue Cycle Management: What Service Providers Need to Know to Survive the Changing Diagnostic Healthcare Environment
Macroeconomic pressure, increased governance, organizational changes, and technological advances are driving pervasive and lasting changes in the fabric of the healthcare system. Because diagnostic services influence the majority of healthcare decisions, changes to healthcare are magnified in the diagnostic services segment. Failure to aggressively adapt to this dynamic environment can easily imperil diagnostic service providers.
Connecting Labs to Physicians’ Electronic Health Records: Effective Strategies for Laboratories to Add Value
The American healthcare system is in the process of significant change. Healthcare represents the fastest growing segment of our GDP, accounting for 17.3% of expenditures in 2009 and 19.3% projected for 20191, with Medicare and Medicaid representing 35% of that segment. Most metrics and outcome measures indicate that our healthcare system is operating inefficiently and that we are not getting our fair share from our investment. There is a broad consensus that these trends are unsustainable and that a change is mandated.
A CEO’s Guide to Molecular Diagnostic Reimbursement: Navigating the Many Challenges of Reimbursement and Commercialization
Reimbursement and commercialization are significant challenges in this era of personalized medicine and comparative effectiveness. Many traditional clinical laboratories and early stage startup companies are trying to enter this space and are struggling to evaluate both the market and its offerings. According to Gene Tests, a publicly funded medical genetics information resource, the availability of new diagnostic tests increases 10% annually.
A CEO’s Guide to Increasing Laboratory Valuation: Effective Revenue Cycle and Compliance Management are Critical Success Factors
There is no doubt that the complexity of laboratory revenue cycle management is unmatched in all of health care. With frequent regulatory and compliance rules changes, ever tightening margins, and a severely weakened economy, it is getting harder and harder for potentially acquirable independent labs to be sure they are not leaving potential profits on the table.